BIOHIT OYJ B revenue breakdown overview

BIOHIT OYJ B revenue for the last year amounted to 14.33 M EUR, the most of which — 14.28 M EUR — came from its highest performing source at the moment, Diagnostic Tests, Acetaldehyde and Monoclonal Antibodies, the year earlier bringing 13.08 M EUR. The greatest contribution to the revenue figure was made by Europe, Other — last year it brought BIOHIT OYJ B 5.74 M EUR, and the year before that — 5.70 M EUR.